tiprankstipranks
Alterity Therapeutics Ltd (ATHE)
NASDAQ:ATHE
US Market

Alterity Therapeutics (ATHE) Income Statement

Compare
283 Followers

Alterity Therapeutics Income Statement

Last quarter (Q4 2024), Alterity Therapeutics's total revenue was AU$2.12M, a decrease of -23.36% from the same quarter last year. In Q4, Alterity Therapeutics's net income was AU$-12.62M. See Alterity Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
AU$ 4.02MAU$ 3.92MAU$ 5.12MAU$ 4.34MAU$ 0.00
Gross Profit
AU$ 3.80MAU$ 3.63MAU$ 4.76MAU$ 3.98MAU$ -112.43K
Operating Expenses
AU$ 23.41MAU$ 17.35MAU$ 17.54MAU$ 19.31MAU$ 10.07M
Depreciation and Amortization
AU$ 147.53KAU$ 102.26KAU$ 54.21KAU$ 75.37KAU$ 112.43K
EBITDA
AU$ -19.57MAU$ -17.51MAU$ -17.39MAU$ -19.36MAU$ -13.34M
Operating Income
AU$ -19.60MAU$ -14.64MAU$ -15.50MAU$ -15.18MAU$ -10.41M
Other Income/Expenses
AU$ 524.33KAU$ 904.68KAU$ 2.72MAU$ -133.04KAU$ 428.68K
Pretax Income
AU$ -19.08MAU$ -13.70MAU$ -12.78MAU$ -15.31MAU$ -10.06M
Net Income
AU$ -19.12MAU$ -13.81MAU$ -12.85MAU$ -15.31MAU$ -9.70M
Per Share Metrics
AU$ ―AU$ ―AU$ ―AU$ ―AU$ ―
Basic EPS
AU$ -0.01AU$ -3.41AU$ -3.20AU$ -5.41AU$ -6.50
Diluted EPS
AU$ -0.01AU$ -3.41AU$ -3.20AU$ -5.41AU$ -6.50
Weighted Average Shares Outstanding
3.65B 4.05M 4.01M 2.83M 1.49M
Weighted Average Shares Outstanding (Diluted)
3.65B 4.05M 4.01M 2.83M 1.49M
Currency in AUD

Alterity Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis